AstraZeneca Recruits Partners for "Latin America Overseas Direction"
Supplier Advantages: This article mainly introduces AstraZeneca's specific partnership needs in the Latin American region (especially Brazil), including cooperation opportunities in areas such as chronic disease screening and diagnostic equipment, respiratory disease solutions, public health medical programs, big data services, active pharmaceutical ingredient production, and smoking cessation devices. At the same time, expected cooperation standards are proposed, such as obtaining local ANVISA approval and the ability to establish an office in Brazil. Additionally, the article outlines the support measures provided by AstraZeneca, including business cooperation expansion, market development assistance, and opportunities to participate in industry exchange activities, aiming to promote mutual growth in the Latin American market.
| Published by | AstraZeneca | Department | -- |
|---|---|---|---|
| Region | England,United Kingdom | Budget | -- |
| Validity | Long-term | ||
1. Recruitment Needs
Partners in the following fields with intentions to expand to Brazil, Argentina, Mexico, and Colombia
Demand 1: Screening and diagnosis for chronic kidney disease, tumors (lung, breast), heart disease, and rare diseases
① Disease detection equipment applicable to hospital inpatient scenarios;
② Disease screening and early diagnosis platforms applicable to grassroots hospital settings, aimed at expanding the accessibility of early diagnosis;
③ Innovative enterprises that can enhance the risk prediction and early screening capabilities for the aforementioned diseases through data algorithms;
Demand Two: Solutions for the respiratory field, including COPD/asthma
① Product Direction: Digital Diagnostics, POCT Testing Devices, Digital Therapeutics or Assistive Treatment Devices;
② The product must have: respiratory function analysis (FEV1, FVC) and the ability to determine abnormal indicators;
③ The product should preferably have: differential diagnosis in the field of respiratory diseases (e.g., COPD, asthma) and can provide auxiliary diagnostic suggestions;
④ Target audience: Patients with respiratory symptoms but not yet diagnosed;
Requirement Three: Public Health Medical Solution
① Based on data and cutting-edge diagnosis and treatment technologies, efficient diagnosis and treatment solutions for primary healthcare scenarios can be provided.
②Medical service solutions for different stages of diagnosis and treatment of tropical diseases
Demand Four: Big data enterprises capable of providing services to transform in-hospital clinical information into databases and real-world research evidence
Requirement Five: API Manufacturers
Demand Six: Enterprises Related to Smoking Control Devices
2. Expected Cooperation Standards
① The solution/platform can collaborate on clinical trials in Brazil through local research and ANVISA approval.
② Able to set up an office in Brazil locally
*ANVISA is the Brazilian Health Regulatory Agency, overseeing medical devices.
3. Project Cooperation Direction
· AstraZeneca Latin America Commercial Collaboration
AstraZeneca Brazil can provide local commercial cooperation partnerships, through which AstraZeneca Brazil will extend solutions to the existing Latin American ecosystem and offer financial support for some pilot/POC projects.
· Overseas Business Expansion Support (Brazil)
AstraZeneca Brazil can provide a local team (headquarters and sales force) to assist partners in expanding their market and business in Brazil.
· Empower Overseas Event Industry Exchange
Participate in the Latin American delegation's visit to China exchange project in early 2024, where in-depth exchanges can be conducted with representatives from the political, industrial, academic, research, medical, and investment sectors of the Latin American ecosystem to explore future cooperation opportunities.